Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anu K. Antony"'
Autor:
Anu K Antony, Rowena Robinson
Publikováno v:
Critical Research on Religion. 11:33-47
The literature emphasizes institutional formation in the process of a young woman becoming a nun or sees her motivations as stemming from expectations of social and economic mobility. This article focuses on the nun’s call as event ( Badiou 2001 ;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56190876c5c4cf41d40fb12c449da333
https://doi.org/10.1177/20503032221148471
https://doi.org/10.1177/20503032221148471
Autor:
Anu K ANTONY, Rowena ROBINSON
Publikováno v:
Social Compass. :003776862311665
Going beyond current sociological and anthropological understandings, the article harnesses Latour’s idea of actant to grasp prayer as a comparatively independent entity, analytically cleavable from the nun’s act of praying. Based on an ethnograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6237f6d069fd3c46ee016541442eee22
https://doi.org/10.1177/00377686231166512
https://doi.org/10.1177/00377686231166512
Autor:
John R. Pfeiffer, Karen Zwicky, Tushar Pandey, Anu K. Antony, The SimBioSys Team, John A. Cole, Clifford Wolf
Publikováno v:
Journal of Clinical Oncology. 40:598-598
598 Background: While most cancer patients are treated at community hospitals, specialized equipment, diagnostic tests, and therapeutic regimens are generally validated at academic settings. Here we present a novel approach to precision medicine to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3be0f9c6307ed5b48accf65426cce220
https://doi.org/10.1200/jco.2022.40.16_suppl.598
https://doi.org/10.1200/jco.2022.40.16_suppl.598
Publikováno v:
Journal of Clinical Oncology. 40:e12551-e12551
e12551 Background: During the I-SPY2 clinical trial, ganitumab (G) immunotherapy (IO) was co-administered with metformin (GM) to counteract G-induced hyperglycemia. The GM + standard of care (SOC) combination showed promising results but did not meet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3664ef3fbe6e30035c2cb4dc2ca19ed8
https://doi.org/10.1200/jco.2022.40.16_suppl.e12551
https://doi.org/10.1200/jco.2022.40.16_suppl.e12551
Publikováno v:
Journal of Clinical Oncology. 40:e12565-e12565
e12565 Background: The 21-gene (Oncotype DX) recurrence score (RS) has been utilized as a prognostic assay in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. The results stratify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58465cb1ce047e370fdb1dfee86b9d07
https://doi.org/10.1200/jco.2022.40.16_suppl.e12565
https://doi.org/10.1200/jco.2022.40.16_suppl.e12565
Autor:
Nicole Liadis, Tyler M Earnest, Eduardo Braun, Anu K. Antony, Micahel J Hallock, The SimBioSys Team, Daniel Cook
Publikováno v:
Journal of Clinical Oncology. 40:e12541-e12541
e12541 Background: Race-related differences in breast cancer incidence and clinical outcome have been well documented, with many studies focusing on socioeconomic determinants contributing to African American (AA) breast cancer patients having higher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af631f8432e2500d60fc018bed93d2b0
https://doi.org/10.1200/jco.2022.40.16_suppl.e12541
https://doi.org/10.1200/jco.2022.40.16_suppl.e12541
Publikováno v:
Journal of Clinical Oncology. 40:e12597-e12597
e12597 Background: Tumor heterogeneity is known to play a key role in drug response and resistance. However, knowledge of tumor heterogeneity is largely limited to genetics and biopsy samples representing one region of the tumor. The study of spatial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dccc3616f5592fce8aad1788804bcffa
https://doi.org/10.1200/jco.2022.40.16_suppl.e12597
https://doi.org/10.1200/jco.2022.40.16_suppl.e12597